Abstract

Digital decision support and remote patient monitoring may improve outcomes and efficiency, but rarely scale beyond a single institution. Over the last 5 years, the platform Timely Interventions for Diabetes Excellence (TIDE) has been associated with reduced care provider screen time and improved, equitable type 1 diabetes care and outcomes for 268 patients in a heterogeneous population as part of the Teamwork, Targets, Technology, and Tight Control (4T) Study (NCT03968055, NCT04336969). Previous efforts to deploy TIDE at other institutions continue to face delays. In partnership with the diabetes technology non-profit, Tidepool, we developed Tidepool-TIDE, a clinic-agnostic, turnkey solution available to any clinic in the United States. We present how we overcame common technical and operational barriers specific to scaling digital health technology from one site to many. The concepts described are broadly applicable for institutions interested in facilitating broader adoption of digital technology for population-level management of chronic health conditions.

Details

Title
The adaptation of a single institution diabetes care platform into a nationally available turnkey solution
Author
Kim, Gloria Y. K. 1   VIAFID ORCID Logo  ; Rostosky, Rea 2 ; Bishop, Franziska K. 3 ; Watson, Kelly 2 ; Prahalad, Priya 4   VIAFID ORCID Logo  ; Vaidya, Aishwari 2 ; Lee, Sharon 2 ; Diana, Alexander 2 ; Beacock, Clint 2 ; Chu, Brian 2 ; Yadav, Ginny 2 ; Rochford, Kaylin 5 ; Carter, Carissa 6 ; Ferstad, Johannes O. 7   VIAFID ORCID Logo  ; Pang, Erica 3 ; Kurtzig, Jamie 3 ; Arbiter, Brandon 2 ; Look, Howard 2   VIAFID ORCID Logo  ; Johari, Ramesh 7   VIAFID ORCID Logo  ; Maahs, David M. 4 ; Scheinker, David 8   VIAFID ORCID Logo 

1  Stanford University School of Medicine, Clinical Informatics Management, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University School of Engineering, Management Science and Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
2  Tidepool, Palo Alto, USA (GRID:grid.468214.d) 
3  Stanford University School of Medicine, Division of Pediatric Endocrinology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
4  Stanford University School of Medicine, Division of Pediatric Endocrinology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Stanford Diabetes Research Center, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
5  Stanford University School of Engineering, Department of Mechanical Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
6  Stanford University, Hasso Plattner Institute of Design, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
7  Stanford University School of Engineering, Management Science and Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956) 
8  Stanford University School of Engineering, Management Science and Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University School of Medicine, Division of Pediatric Endocrinology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Stanford Diabetes Research Center, Stanford, USA (GRID:grid.168010.e) (ISNI:0000 0004 1936 8956); Stanford University School of Medicine, Clinical Excellence Research Center, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
Pages
311
Publication year
2024
Publication date
Dec 2024
Publisher
Nature Publishing Group
e-ISSN
23986352
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1038/s41746-024-01319-x
ProQuest document ID
3124960662
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.